Presenilin 1 (PS1) regulates ␤-catenin stability; however, published data regarding the direction of the effect are contradictory. We examined the effects of wildtype and mutant forms of PS1 on the membrane, cytoplasmic, nuclear, and signaling pools of endogenous and exogenous ␤-catenin by immunofluorescence microscopy, subcellular fractionation, and in a transcription assay. We found that PS1 destabilizes the cytoplasmic and nuclear pools of ␤-catenin when stabilized by Wnt or Dvl but not when stabilized at lower levels of the Wnt pathway. The PS1 mutants examined were less able to reduce the stability of ␤-catenin. PS1 also inhibited the transcriptional activity of endogenous ␤-catenin, and the PS1 mutants were again less inhibitory at the level of Dvl but showed a different pattern of inhibition toward transcription below Dvl. The transcriptional activity of exogenously expressed wild-type ␤-catenin and two mutants, ⌬N89␤-catenin and ⌬ST␤-catenin, were also inhibited by wild-type and mutant PS1. We conclude that PS1 negatively regulates the stability and transcriptional activity of ␤-catenin at different levels in the Wnt pathway, that the effect on transcriptional activity appears to be independent of the GSK-3␤ mediated degradation of ␤-catenin, and that mutations in PS1 differentially affect the stability and transcriptional activity of ␤-catenin.
Presenilin 1 (PS1) regulates ␤-catenin stability; however, published data regarding the direction of the effect are contradictory. We examined the effects of wildtype and mutant forms of PS1 on the membrane, cytoplasmic, nuclear, and signaling pools of endogenous and exogenous ␤-catenin by immunofluorescence microscopy, subcellular fractionation, and in a transcription assay. We found that PS1 destabilizes the cytoplasmic and nuclear pools of ␤-catenin when stabilized by Wnt or Dvl but not when stabilized at lower levels of the Wnt pathway. The PS1 mutants examined were less able to reduce the stability of ␤-catenin. PS1 also inhibited the transcriptional activity of endogenous ␤-catenin, and the PS1 mutants were again less inhibitory at the level of Dvl but showed a different pattern of inhibition toward transcription below Dvl. The transcriptional activity of exogenously expressed wild-type ␤-catenin and two mutants, ⌬N89␤-catenin and ⌬ST␤-catenin, were also inhibited by wild-type and mutant PS1. We conclude that PS1 negatively regulates the stability and transcriptional activity of ␤-catenin at different levels in the Wnt pathway, that the effect on transcriptional activity appears to be independent of the GSK-3␤ mediated degradation of ␤-catenin, and that mutations in PS1 differentially affect the stability and transcriptional activity of ␤-catenin.
Mutations in the two closely related presenilin (PS)
1 genes are the most frequent cause of familial Alzheimer's disease (FAD) (1) . The PS gene products, PS1 and PS2, are ubiquitously expressed membrane proteins, and although their functions have not been fully determined, disease-causing mutations in PS1 and PS2 have been shown to increase the production of the longer, more amyloidogenic forms of the amyloid ␤-peptide (2-6). More recently it was shown that PSs are necessary for the ␥-secretase cleavage of ␤-amyloid precursor protein (7) (8) (9) (10) (11) either performing, or regulating, this final cleavage step in amyloid ␤-peptide production and that they are also necessary for the S3 (␥-secretase-like) cleavage of Notch (11) (12) (13) , which releases the Notch intracellular domain allowing it to activate gene transcription.
Several groups have demonstrated that PS1 can bind the Armadillo homologue, ␤-catenin (14 -17) . ␤-Catenin acts both as an adhesion molecule in adherens junctions where it links cadherins to the cytoskelton via ␣-catenin and as an effector molecule in the Wnt (Wingless in Drosophila) signaling pathway. However the significance, if any, of the PS1/␤-catenin interaction for Wnt signaling, cell adhesion, or disease has yet to be determined.
Several reports (15, (17) (18) (19) have shown that PS1 affects the stability of ␤-catenin, although the data are contradictory as to whether PS1 is a positive or negative regulator and whether mutant forms of PS1 (PS1mts) have increased or decreased effects over wild-type PS1 (PS1wt). More recently Soriano et al. (20) have confirmed their earlier findings (17) that PS1wt is a negative regulator of ␤-catenin stability and that PS1mts are less effective. Their findings are supported by genetic evidence from Drosophila (21, 22) , which shows that the single PS homologue, DPS, is an Armadillo antagonist. However, conflicting observations are still being reported, Kirschenbaum et al. (23) found that both PS1wt and PSmts have no effect on ␤-catenin stability, while Kawamura et al. (24) found that the mutant PS1 M146L increased ␤-catenin turnover in comparison with wild-type.
In an attempt to further clarify the role of PS1 in modulating ␤-catenin turnover and activity, we have compared wild-type and mutant PS1 effects on ␤-catenin due to activation of the Wnt pathway at the level of Wnt, Dvl, FRAT, GSK-3, and overexpression of ␤-catenin itself. We examined the effect of PS1 on ␤-catenin in three ways, by immunofluorescence microscopy, immunoblotting of subcellular fractions, and in a ␤-catenin/Tcf-dependent luciferase transcription assay. Our findings suggest a dysjunction between the cellular and signaling competent fraction of ␤-catenin that is differentially affected by PS1.
HEK293 cells selected for its greater adherence (Quantum Biotechnologies, Canada)) were grown in Dulbecco's modified Eagle's medium and CHO cells in F-12 nutrient mix/Ham. Media were obtained from Life Technologies, Inc. and supplemented with 10% (v/v) fetal bovine serum, 2 mM L-glutamine, 100 IU penicillin, and 100 g/ml streptomycin.
DNA Constructs-Human Dvl1 and Dvl3 cDNAs were generous gifts from Dr. A. Pizzuti and Dr. G. Novelli, respectively. Engineering of Myc-tagged and untagged Dvl1, Dvl2, and Dvl3 expression constructs in pCIneo has been described previously (25) . The 1.4-kb human PS1wt coding sequence (from the ATG start to the TAG stop site, lacking nucleotides that encode the alternatively spliced VRSQ motif) was amplified by PCR using primers that incorporated an XbaI site and a modified Kozak sequence at the 5Ј end and an EcoRI site at the 3Ј end. The amplified product was cloned into pcDNA3(Ϫ) (Invitrogen) and verified by sequencing.
PS1 mutants, C263R and P264L, were created from the above clone by extension overlap PCR whereby two overlapping amplified products were generated. The first product was generated using a 5Ј primer containing a unique PflmI site and a 3Ј primer containing the nucleotides encoding C263R or P264L. The second product was generated using a 5Ј primer containing the nucleotides encoding C263R or P264L and a 3Ј primer containing a unique BsrGI site. The product of amplification of the first two products was then digested with PflmI and BsrGI and subcloned into the same sites of the above PS1wt clone in pcDNA3(Ϫ). Mutagenesis was confirmed by sequencing.
The PS1 aspartate mutants, D257A and D385A, were generated by PCR-based site-directed mutagenesis. In brief, oligonucleotide pairs with alanine codons substituting for the aspartate residues Asp 257 and Asp 385 were synthesized for use as PCR primers. The amplification was performed using Turbo Pfu polymerase (Stratagene). The resulting product was digested with DpnI, transformed, and screened by restriction digest. Mutagenesis was confirmed by sequencing.
Human c-Myc-tagged Wnt1 (Wnt1-myc) and FLAG-tagged murine FRAT1, both in pcDNA3.1, were kind donations from Dr. Trevor Dale. Wild-type human ␤-catenin and the mutant, ⌬ST␤-catenin, in which the four consensus N-terminal GSK-3␤ phosphorylation sites (serine and threonine residues 33, 37, 41, and 45) have been substituted by alanine, were generous gifts from Dr. Rolf Kemler. The deletion mutant ⌬N89␤-catenin, which lacks the GSK-3␤ phosphorylation sites, was kindly donated by Dr. Paul Polakis. The pTOPflash/pFOPflash luciferase reporter constructs were kind donations from Dr. Hans Clevers.
Production of Antibodies-Peptides were synthesized, corresponding to unique regions of each of the three human Dvl isoforms (Dvl1, amino acids 557-571; Dvl2, amino acids 600 -614; Dvl3, amino acids 582-596) with the addition of N-terminal cysteine residues to aid conjugation to carrier protein. The peptides were conjugated to keyhole limpet hemocyanin and used to raise polyclonal antisera in SPF rabbits. Rabbits received 7 immunizations over a 20-week schedule, and the antisera were purified by salt precipitation. Each antiserum was tested extensively by Western blotting against total cell lysates of HEK293A cells that had been individually transfected with the human recombinant Dvl isoforms to determine their specificity and to ensure that there was no cross-reactivity between isoforms. Peptide blocking was performed and abolition of antibody reactivity (on blots) was achieved with Ͻ1 nmol of synthetic peptide/ml of antiserum.
Rabbit polyclonal antiserum to ␤-catenin was raised against a glutathione S-transferase fusion protein of full-length ␤-catenin, and a rabbit polyclonal antiserum to PS1 was raised against a synthetic peptide corresponding to human PS1 amino acids 1-25 coupled to tuberculin-purified protein derivative. Each rabbit received four immunizations over a 20-week period, and the unpurified sera were used. The resulting antisera recognized full-length ␤-catenin and the 48-kDa holoprotein and 28-kDa N-terminal cleavage product of PS1, respectively.
Transfection-Cells were plated at the appropriate densities and allowed to attach overnight. DNA was transfected with LipofectAMINE diluted in Optimem (both from Life Technologies, Inc.) according to the manufacturer's instructions. In multiple transfections the amount of DNA was kept constant by the addition of the appropriate empty vector plasmids. Cells were harvested at set time points after transfection for blotting and the luciferase assay or were fixed for immunofluorescence microscopy 24 h post-transfection in methanol at Ϫ20°C for 10 min.
Treatment of Cells with Lithium Chloride-HEK293A cells were transfected as described above. Medium was removed 20 h post-transfection and replaced with fresh medium containing LiCl at the appropriate concentrations (1-25 mM). Cells were allowed to grow for 4 h and then fixed or lysed for subsequent analysis.
Cell Fractionation for ␤-Catenin Distribution-Twenty-four hours post-transfection, cells in 10-cm Petri dishes were washed twice in ice-cold PBS and mechanically disrupted with scraping into 0.8 ml of homogenization buffer (10 mM HEPES, pH 7.4, 1 mM EDTA, 0.25 M sucrose) plus Complete mini-protease inhibitors (Roche Molecular Biochemicals) at 4°C. Cell fragments were further disrupted by ten strokes of a Dounce homogenizer followed by five passages through a 27-gauge needle. Cell disruption was confirmed by phase contrast microscopy. The lysate was centrifuged at 600 ϫ g (av) for 10 min at 4°C and the supernatant removed and placed on ice. The pellet was resuspended in 0.5 ml of homogenization buffer and centrifuged at 600 ϫ g (av) for 10 min at 4°C, the resultant pellet was the nuclear fraction. The supernatants were combined and centrifuged at 100,000 ϫ g (av) for 1 h at 4°C in an ultracentrifuge (Beckman TL-100) to produce membrane (pellet) and cytosolic (supernatant) fractions. The fractions were analyzed by Western blotting for ␤-catenin.
Immunofluorescence Microscopy of Transfected Cells-Cells grown on glass coverslips in 12-well plates were transfected and fixed as described above. Following fixation the coverslips were incubated at room temperature in blocking/permeablization solution (PBS, 3% (w/v) bovine serum albumin, and 0.1% (v/v) Triton X-100) for 30 min. The coverslips were then incubated with primary antibodies at the appropriate concentration in blocking solution (PBS, 3% (w/v) bovine serum albumin) for 1 h. Double immunolabeling was performed using Alexa Fluor TM 568 goat anti-rabbit IgG conjugate and Alexa Fluor TM 488 goat anti-mouse IgG conjugate secondary antibodies (Molecular Probes). Finally coverslips were briefly immersed in 0.5 g/ml bisbenzimide (Sigma) in PBS, washed, mounted, and visualized using a Zeiss Axioscope. Images were captured using a Pentamax digital camera (Princetown Instruments) and Metamorph imaging software.
SDS-PAGE and Western Blotting-Protein samples were made up in Laemmli sample buffer (26) , heated at 37°C for 45 min, and briefly centrifuged. Samples were separated by SDS-PAGE on 7.5% (w/v) polyacrylamide gels, at 150 V. Proteins were transferred to polyvinylidene difluoride membranes (Schleicher and Schuell) using a TransBlot semidry electroblotter (Bio-Rad) at 15 V for 40 min. Membranes were blocked in Tris-buffered saline (TBS) containing 0.2% (v/v) Tween 20 and 3% (w/v) dried skimmed milk (TBS-T-M) and then incubated overnight at 4°C with the relevant primary antibodies diluted to the appropriate concentration in TBS-T-M. After washing blots were incubated for 1 h with the appropriate secondary immunoglobulins and detected by ECL (Amersham Biosciences Inc.).
Cell Counting-As an assay for the Wnt signal in transfected cells, nuclear translocation of ␤-catenin was assessed in those cells that also stained positively with antibodies to the transfected proteins. Of the transfected cells identified only those that exhibited strong staining of ␤-catenin in the nucleus were scored as positive for ␤-catenin nuclear translocation. ␤-Catenin antibodies did not stain the nuclei of control cells in untransfected cultures or those cells transfected with an enhanced green fluorescent protein construct, which was employed as a control for nonspecific effects on endogenous ␤-catenin levels by transfection of plasmid DNA. Cells positively identified as having been transfected with the constructs, but whose nuclei were unstained with the ␤-catenin antibodies or in which positive staining was questionable, were deemed to have no nuclear translocation of ␤-catenin and were scored as negative. The quantitative data were averages taken from five independent experiments with a minimum of 200 cell counts in each experimental condition and were expressed as percentages of the appropriate control cultures. Significance levels were determined by logistic regression for grouped data (Wald test) using the STATA software package. The S.D. was calculated from the variation of the data across the five experiments.
Luciferase Reporter Assay-HEK293A cells were seeded at 1 ϫ 10 5 / well in six-well plates, cultured for 24 h, and transefected with 300 ng of the pTOPflash or pFOPflash luciferase reporter constructs and 500 ng of the Wnt pathway components plus either PS1wt or one of the PS1mts. A constant amount of DNA was maintained by the addition of appropriate empty vector plasmid. Twenty-four hours post-transfection the media was removed and the cells lysed for 5 min in 300 l of Bright-Glo lysis buffer (Promega). The lysate was removed, vortexed, and briefly spun in a microcentrifuge. 150 l of lysate supernatant was then combined with 150 l Bright-Glo luciferase assay reagent (Promega, half-life 30 min) and placed into a 24-well reader plate. Remaining lysate was used to check transfection efficiencies and expression levels by Western blotting. Luciferase activity was immediately measured in a Wallac 1450 Microbeta Trilux luminometer (PerkinElmer Life Sciences). The data presented are pooled from Ͼ4 replica experiments. Statistical significance levels were determined by one way ANOVA.
RESULTS
Wild-type and Mutant PS1 Differentially Antagonize Wntstabilized ␤-Catenin-To investigate the effects of PS1 on Wnt signaling, HEK293A cells were transfected with a c-Myctagged Wnt1 construct (Wnt1-Myc) or co-transfected with Wnt1-myc and PS1 and stained for endogenous ␤-catenin, since it has been shown that expression of Wnt1 in HEK293 cells activates T-cell factor/lymphoid enhancer factor-dependent gene transcription following translocation of ␤-catenin to the nucleus (27) . Standard HEK293 and CHO cells were also transfected to ensure that the results obtained were not restricted to one particular cell type. The results were similar in both cell types, and data are presented only from HEK293A cells. An enhanced green fluorescent protein expression construct was used as a nonspecific control to identify transfected cells. The levels of ␤-catenin and its cellular distribution were the same in untransfected cells and cells expressing enhanced green fluorescent protein. Similarly, we observed no changes in ␤-catenin levels between untransfected cells and control cells when transfected with the relevant empty vector plasmid DNA (data not shown).
In contrast to control cells, cells expressing Wnt1-Myc (Fig.  1A ) possessed strong nuclear and increased cytoplasmic ␤-catenin immunoreactivity. Cells that did not express Wnt1-Myc but were in proximity to the Wnt1-Myc-transfected cells also showed evidence of ␤-catenin stabilization (Fig. 1B) , consistent with Wnt1 being a secreted signaling protein and therefore not limited to an autocrine effect. Since Wnt1-Myc transfection reliably increased levels of nuclear ␤-catenin, we used this as an assay for Wnt signaling for further experiments.
Cells were next transfected with Wnt1-myc alone or doubly transfected with Wnt1-Myc and PS1wt. The cells were labeled with a rabbit polyclonal antibody to PS1 and by a monoclonal antibody recognizing the Wnt1-Myc tag (9E10) and the proportion of total cells (determined by bisbenzimide staining) expressing both calculated.
In doubly transfected (Wnt1-Myc and PS1wt) cells ␤-catenin expression was low and largely cytoplasmic, similar to untransfected cells (Fig. 1, C and D) , whereas in cells expressing Wnt1 only ␤-catenin expression was increased and was nuclear predominant (Fig. 1B) . We next compared the ability of mutant PS1 (two FAD missense mutations, C263R and P264L, a FAD deletion mutation, ⌬9, and two mutations that change the putative active site aspartate residues, D257A and D385A) to antagonize Wnt1-induced ␤-catenin stabilization. All mutants were significantly less effective at attenuating Wnt1-induced ␤-catenin stabilization than PS1wt (Fig. 1E , p Ͻ 0.01; n ϭ 5), but the three mutants that do not undergo endoproteolytic cleavage (PS1 ⌬9 and the artificial aspartate mutants PS1 D287A and PS1 D385A) were the least effective and were not different from control cells indicating a complete loss of function with regard to antagonizing ␤-catenin nuclear translocation.
PS1 Antagonizes the Transcriptional Activity of Wnt-stabilized ␤-Catenin-We then repeated the above transfections in conjunction with a Tcf/luciferase reporter construct as a measure of ␤-catenin function. Similar results were obtained in that Wnt1 increased ␤-catenin-dependent transcription, as measured by increased luciferase activity, and this was inhibited by PS1wt. All the PS1 mutants were less effective in this attenuation, and as before, the mutants that do not undergo cleavage showed greater loss of function than the point missense FAD mutations (Fig. 1F) . The pattern of antagonistic effects was very similar to the data obtained by counting the proportion of cells with ␤-catenin-positive nuclei (compare Fig. 1, E and F) .
To ensure that equal levels of PS1wt and PS1mt protein were . p values were determined by the Wald test: *, p Ͻ 0.01 (PS1wt was compared with Wnt alone, the PS1 mutants were compared with PS1wt). F, luciferase transcription assay. Cells were co-transfected with pTOPflash, Wnt1-Myc, and either empty pcDNA3 control DNA, PS1wt, or one of the PS1mts. Cells were lysed and luciferase activity measured. The bar chart represents pooled data from four replica experiments. p values were determined by one way ANOVA (PS1wt was compared with Wnt alone, the PS1mts were compared with PS1wt). three isoforms were found in a punctate distribution throughout the cytoplasm (Fig. 2, A, C, and E) , similar to the staining pattern previously reported for Dvl1 (28, 29) and Dvl2 (30) . When these cells were stained for ␤-catenin Dvl-expressing cells showed an increase in levels of cytoplasmic ␤-catenin and nuclear translocation of ␤-catenin (Fig. 2, B, D, and F) .
Presenilin-1 Antagonizes Dvl Stabilization of ␤-CateninThe effects of wild-type and mutant forms of PS1 on ␤-catenin stabilization induced by overexpression of Dvl1, Dvl2, and Dvl3 were investigated using the ␤-catenin nuclear translocation assay. Co-expression of PSwt with Dvl1 consistently resulted in a marked reduction in ␤-catenin stabilization, comparable with its effects on the Wnt1-induced stabilization of ␤-catenin. As for experiments using Wnt1, PS1wt attenuated Dvl-mediated increases in ␤-catenin activity, but the mutants were less effective than PS1wt (p Ͻ 0.01; n ϭ 5 in all cases) (Fig. 2G) . Again, as before, the PS1 ⌬9, D287A, and D385A mutants showed complete loss of function, whereas the PS1 C263R and P264L mutants demonstrated partial antagonism of Dvl1. PS1wt similarly antagonized Dvl2-and Dvl3-induced ␤-catenin nuclear translcoation (Fig. 2G) . These experiments were then repeated using the Luciferase reporter assay with very similar results as seen against Wnt1 stabilzed ␤-catenin (Fig. 2H) .
Subcellular Fractionation Confirms That PS1 Antagonizes the Cytoplasmic and Nuclear Pools of ␤-Catenin
When Stabilized by Dvl1-To confirm these observations biochemically, HEK293A cells and CHO cells were transfected with Dvl1; separated into nuclear, membrane, and cytosolic fractions; and examined by immunoblotting (Fig. 2I) . Expression of Dvl1 resulted in a marked increase in ␤-catenin in all three fractions (compare lanes 1 and 3) . This increase was attenuated by co-transfection of PS1wt (lane 4), although PS1 by itself had no effect (lane 2).
PS1 Does Not Antagonize ␤-Catenin Nuclear Translocation Induced by FRAT1-We next examined if PS1 would antagonize ␤-catenin when stabilization occurred below the level of Dvl. Activation of Dvl recruits FRAT into the axin complex, which stabilizes ␤-catenin by preventing it from being phosphorylated by GSK-3␤ (31-33). HEK-293A cells were transfected with FLAG-tagged FRAT1 and the cells stained with anti-FLAG and anti-␤-catenin antibodies. As expected, cells expressing FRAT1 (Fig. 3A) showed increased cytoplasmic and nuclear staining for ␤-catenin (Fig. 3B) . HEK293A cells were then doubly transfected with FRAT1 and either PS1wt or PS1 ⌬9 and the cells double labeled with antibodies to PS1 and ␤-catenin. The proportion of cells that exhibited nuclear ␤-catenin staining did not change when FRAT1 was co-transfected with PS1wt or the PS1 ⌬9 mutant (Fig. 3C) . The four other PS1 ␤-catenin (B, D, and F) , demonstrating stabilization of ␤-catenin by increased cytoplasmic levels and nuclear translocation of endogenous ␤-catenin. G, bar chart comparing the antagonistic effects of PS1wt on ␤-catenin stabilization induced by overexpression of Dvl1, Dvl2, and Dvl3, as well as the antagonistic effects of PS1mts on ␤-catenin stabilization induced by Dvl1: each bar represents data (mean Ϯ S.D.) for translocation to the nucleus of ␤-catenin from five independent experiments. p values were determined by the Wald test: *, p Ͻ 0.05 (PS1wt was compared with Dvl alone, the PS1 mutants were compared with PS1wt). H, PS1 inhibits ␤-catenin-dependent transcription induced by Dvl1. Cells were co-transfected with pTOPflash, Dvl1, and either pcDNA3, PS1wt, or one of the PS1mts. Cells were lysed and luciferase activities measured. The pooled data from four experiments are presented. p values were determined by one way ANOVA (PS1wt was compared with Wnt alone, the PS1 mutants were compared with PS1wt). I, subcellular fractionation of HEK293 cells transfected with Dvl1 and/or PS1wt. Cells were separated into nuclear, membrane, and cytosolic fractions and immunoblotted for ␤-catenin. Overexpression of PS1wt had no effect on the subcellular distribution of ␤-catenin compared with untransfected cells (compare lanes 1 and 2) . Dvl1 increased endogenous ␤-catenin in all three cellular fractions (lane 3). Co-expression of PS1wt with Dvl1 reduced the ␤-catenin levels in all three fractions (lane 4). mutants also had no effect on FRAT1-stabilized ␤-catenin (data not shown).
PS1 Inhibits ␤-Catenin Transcriptional Activity Due to FRAT1 Stabilization-Despite the apparent lack of effect of PS1 on FRAT1-stabilized ␤-catenin, we examined whether PS1 would still affect FRAT1-induced increases in ␤-catenin-dependent transcriptional activity. HEK293A cells were transfected with pTOPflash and FRAT1 alone or FRAT1 plus PS1wt or one of the PS1mts. Fig. 3D shows that PS1wt and the PS1mts inhibited FRAT1-induced increases in luciferase activity even though no changes in nuclear translocation were detected by immunofluorescence microscopy. Of the PS1 mutants only PS1 ⌬9 showed a significant difference in transcriptional inhibition (p Ͻ 0.05) when compared with PS1wt.
PS1 Does Not Antagonize ␤-Catenin Nuclear Translocation Induced by Lithium-Lithium chloride is a potent inhibitor of GSK-3␤ (34) and as such mimics Wnt signaling and stabilizes ␤-catenin. We treated untransfected HEK293A cells and cells transfected with PS1wt and the FAD PS1mts with 1-25 mM LiCl for 4 h. Cells were then double labeled with antibodies to PS1 and ␤-catenin to assess the proportion of PS1 overexpressing cells that had an elevated level of nuclear ␤-catenin. The proportion of cells stained for nuclear ␤-catenin at each concentration of LiCl are given in table form in Fig. 1E . Overexpression of PS1wt or the FAD PS1mts had no effect on the LiCl-induced nuclear translocation of ␤-catenin.
PS1 Inhibits ␤-Catenin Transcriptional Activity Due to Lithium Stabilization-As PS1 still affected FRAT1-induced increases in ␤-catenin-dependent transcription, despite the apparent lack of effects on FRAT1-induced nuclear translocation, we examined whether PS1 would affect increased transcriptional activity due to LiCl inhibition. HEK293A cells were transfected with pTOPflash and PS1wt or one of the PS1mts. Twenty hours post-transfection cells were treated with 20 mM LiCl, lysed 4 h later, and luciferase activity measured. Fig. 3F shows that PS1wt and the PS1mts all inhibited increases in luciferase activity induced by lithium, although no changes in nuclear translocation were seen by immunofluorescence microscopy. The pattern of the inhibitory effects of the mutants were similar to those observed when ␤-catenin stabilization was induced by FRAT1 and different to those seen against Wnt-and Dvl-stabilized ␤-catenin activity. The PS1 ⌬9 was the only mutant with significantly reduced inhibition toward ␤-catenin-dependent transcription compared with PS1wt.
From the data indicated above it appears that PS1 antagonizes the cytoplasmic and nuclear pools of endogenous ␤-catenin when stabilized by Wnt1 or either of the Dvl isoforms but not when stabilized by FRAT1 or GSK-3␤ inhibition. However, PS1 did affect the transcriptional activity of ␤-catenin when stabilized at all four levels of the Wnt pathway. Differences between wild-type and mutant PS1 were observed only when PS1 antagonized Wnt signaling at the level of Dvl or above, apart from PS1 ⌬9, which had a reduced inhibitory effect at all levels. We next examined the effect of PS1 on exogenously expressed ␤-catenin.
PS1 Inhibits the Transcriptional Activity of Exogenously Expressed ␤-Catenin-To explore further this apparent discrepancy between nuclear translocation and transcriptional activity, we performed separate experiments in which cells were transfected with cDNA coding either for wt ␤-catenin or either of two mutant forms of ␤-catenin, ⌬N89␤-catenin and ⌬ST␤-catenin, which lack or have mutated GSK-3␤ phosphorylation sites and cannot be degraded as a consequence of Wnt signaling. In cells transfected with either wild-type or the mutant ␤-catenins an increase in ␤-catenin activity was observed using the Tcf reporter assay showing that neither the N-terminal inhibits ␤-catenin-dependent transcription induced by FRAT1. Cells were co-transfected with pTOPflash, FRAT1, and either pcDNA3, PS1wt, or one of the PS1mts. Cells were lysed and luciferase activity measured. The pooled data from four replica experiments are presented. p values were determined by one way ANOVA (PS1wt was compared with FRAT1 alone, the PS1 mutants were compared with PS1wt). E, PS1 does not affect lithium-induced ␤-catenin nuclear translocation. HEK293 cells, either untransfected or transfected with wildtype PS1 or the three FAD mutant forms of PS1, were treated with 0 -25 mM lithium chloride for 4 h then double labeled for PS1 and ␤-catenin. The values are the means (Ϯ S.D.) from five independent experiments for each LiCl concentration. F, PS1wt and PS1mts inhibit increased ␤-catenin-dependent transcriptional activity induced by lithium. Cells were co-transfected with pTOPflash and either pcDNA3, PS1wt, or one of the PS1mts and treated with 20 mM LiCl for 4 h. Cells were then immediately lysed and luciferase activities measured. The pooled data from four replica experiments are presented. p values were determined by one way ANOVA (PS1wt was compared with LiCl alone, the PS1 mutants were compared with PS1wt). deletion nor the point mutations affected transcriptional activity. The cellular levels of both wild-type and mutant forms of ␤-catenin were stable and unaffected by the presence or absence of PS1 as expected (Fig. 4A) . However, despite the stability of exogenous ␤-catenin both PS1wt and all the PS1mts reduced ␤-catenin-dependent transcription as measured by the luciferase assay (Fig. 4, B, C, and D) . PS1 ⌬9 was again less inhibitory than PS1wt toward ␤-catenin transcriptional activity; however, the effect was not statistically significant with all forms of exogenously expressed ␤-catenin.
DISCUSSION
Several authors have reported contradictory findings regarding the effects of PS1 on ␤-catenin. We have examined the effects of both the wild-type and mutant forms of PS1 on ␤-catenin stabilization and its function as a transcriptional activator. By using several different approaches and examining both endogenous ␤-catenin, stabilized by mimicking Wnt signaling at several levels in the Wnt pathway, and overexpressed ␤-catenin, we have found that PS1 exerts independent effects on ␤-catenin stability and function. PS1wt antagonized the stabilization of the cytoplasmic and nuclear pools of ␤-catenin induced by Wnt1 or all three Dvl isoforms. PS1wt also inhibited the transcriptional activity of ␤-catenin at these levels as would be predicted following reductions in the nuclear pool of ␤-catenin. Below the level of Dvl PS1wt no longer antagonized ␤-catenin stabilization but did continue to inhibit its transcriptional activity. The effect on transcription at these levels was independent of any detectable changes in the membrane, cytoplasmic, or nuclear pools of ␤-catenin. PS1wt also affected the transcriptional activity of overexpressed wild-type ␤-catenin and the ⌬N89␤-catenin and ⌬ST␤-catenin mutants, which cannot be degraded by the GSK-3␤/ubiquitin pathway, but again did not affect their cellular stability.
The PS1mts we examined also affected ␤-catenin levels and function. At the level of Dvl and above the mutants all showed loss of function with respect to both ␤-catenin stability and transcriptional activity. Mutations affecting PS1 cleavage showed total loss of function whereas the point mutations only partially reduced the PS1 attenuation of Wnt signaling to ␤-catenin. Below the level of Dvl, PS1 reduced ␤-catenin-induced gene transcription without affecting cellular stability, and there was no significant difference between the mutants and wild-type PS1 apart form the ⌬9 mutant, which was consistently less inhibitory at all levels examined (although this effect was not statistically significantly against the exogenously expressed forms of ␤-catenin).
We conclude that PS1 is a negative regulator of both ␤-catenin stabilization and its function as a transcriptional activator, that its effect on transcription is not dependent on GSK-3␤ phosphorylation of ␤-catenin, and that mutant forms of PS1 can exhibit decreased activities or no change in activity in comparison with PS1wt depending on whether the stability or function of ␤-catenin is being measured. That PS1 has different effects on ␤-catenin stabilization and its transcriptional activity and that mutations in PS1 can affect stabilization and transcription differently may help to clarify some of the previous, apparently contradictory, data.
The Wnt pathway is regulated at many levels by a growing number of proteins. In our experiments we exogenously overexpressed PS1 and certain of the Wnt pathway components generating protein levels much higher than normally found under physiological conditions. It remains to be determined then if PS1 regulates Wnt signaling in vivo and whether mutant forms of PS1 have any significant affect on the Wnt pathway in human brain. However, in this regard, the genetic data from lower vertebrates (21) support the view that PS1 nega-FIG. 4. PS1 does not affect stabilization of exogenously expressed ␤-catenin but does inhibit their transcriptional activity. A, subcellular fractionation of HEK293 cells transfected with wildtype and the ⌬N89 and ⌬ST mutant form of ␤-catenin, separately and in conjunction with PS1wt. Cells were separated into nuclear (n), membrane (m), and cytosolic (c) fractions and immunoblotted for ␤-catenin. Overexpression of PS1wt had no effect on the subcellular distribution or levels of endogenous ␤-catenin compared with untransfected cells (com- pare lanes 1 and 2) . Overexpressed wild-type, ⌬N89␤-catenin, and ⌬ST␤-catenin were present in all subcellular fractions, (lanes 3, 5, and  7) . The higher mobility of ⌬N89␤-catenin* and lower mobility of tagged ⌬ST␤-catenin** made them distinguishable from endogenous ␤-catenin. Co-expression of PS1wt with ␤-catenin (lane 4), ⌬N89␤-catenin (lane 6), and ⌬ST␤-catenin (lane 8) had no effect on nuclear, membrane, or cytoplasmic levels. B-D, PS1wt and PS1mts still inhibited the transcriptional activity of exogenously expressed wild-type and mutant ␤-catenin. B, cells were co-transfected with pTOPflash, wild-type ␤-catenin, and either pcDNA3, PS1wt, or one of the PS1mts. In C and D wild-type ␤-catenin was substituted by ⌬N89␤-catenin and ⌬ST␤-catenin, respectively. Cells were lysed and luciferase activities measured. The pooled data from Ͼ4 experiments for each catenin construct are presented. p values were determined by one way ANOVA (PS1wt was compared with either wild-type ␤-catenin, ⌬N89␤-catenin, or ⌬ST␤-catenin alone, and the PS1mts were compared with PS1wt).
tively regulates Wingless/Wnt under physiological conditions as does recent data from rescued PS1 Ϫ/Ϫ mice, which develop skin tumors due to misregulation of ␤-catenin (35) .
Our finding that PS1wt, and certain of the mutants, can inhibit ␤-catenin transcriptional activity independently of GSK-3␤ phosphorylation and overall cytosolic/nuclear levels would appear to be at odds with the currently accepted sequence of events in the Wnt signaling cascade. In the canonical pathway a Wnt signal inhibits GSK-3␤, prevents ␤-catenin degradation, and allows cytoplasmic levels to increase. ␤-Catenin is then thought to freely enter the nucleus and mediate transcription by binding to Tcf and alleviating its repression on transcription. However, Gumbiner and co-workers (36) have shown that epithelial-cadherin (E-cadherin) can inhibit ␤-catenin/Tcf signaling without observable changes in the cytosolic or nuclear levels of ␤-catenin. They argue that there exists a small fraction of total ␤-catenin that can bind to both the cytoplasmic domain of E-cadherin and to Tcf. The activity of this "signaling competent" pool of ␤-catenin is regulated independently of overall cytosolic/nuclear levels by its binding to E-cadherin. A possible interpretation of our data is that PS1 affects this signaling competent pool of ␤-catenin independently of its affects on ␤-catenin levels mediated higher up in the Wnt pathway.
PS1 is a transmembrane protein found mainly in the endoplasmic reticulum (37) and Golgi (38) , but also in the plasma and synaptic membranes (39) , where it can associate with both ␤-catenin and cadherins. PS1 has also been found located in the nuclear membrane (40) where it could play a role in regulating entry of the signaling competent fraction of ␤-catenin into the nucleus. However, it has recently been demonstrated that PS1 binds directly to the cytoplasmic domain of E-cadherin in the membrane-proximal region at residues 604 -615 (41) . This same region of E-cadherin is required for the binding of another catenin, p120
cat . Thus, PS1 and p120 cat compete for binding to E-cadherin. Baki et al. (41) have also shown that PS1 binding to this juxtamembrane domain of E-cadherin stimulates Ecadherin binding to ␤-catenin and in so doing promotes association of the junctional complex with the cytoskeleton. In light of these recent findings (36, 41) a possible explanation of our observations is that PS1, in promoting ␤-catenin binding to E-cadherin, is depleting the signaling-competent pool of ␤-catenin and in so doing exerting an inhibitory effect on ␤-catenin/ Tcf transcription. In support of this idea, the mutant that we found to have the least effect on ␤-catenin transcriptional activity, PS1 ⌬9, was the same mutant that Baki et al. (41) found had no effect cadherin/catenin binding. Interestingly, ␦-catenin, a binding partner of PS1, which is preferentially expressed in brain (14) , shares close homology to p120
cat . It is feasible that a similar competitive mechanism could exist between PS1 and ␦-catenin that may regulate neuronal gene expression.
An outstanding question is what molecular modifications might distinguish the signaling competent pool of ␤-catenin from the refractory pool. Roura et al. (1999) (42) have shown that ␤-catenin is phosphorylated by pp60 c-src at Tyr 86 and Tyr 654 and that phosphorylation at Tyr 654 in particular decreases its binding efficiency to E-cadherin. Recently, the same group (43) has shown that the addition of a phosphate at residue 654 of ␤-catenin reduces its binding to E-cadherin. This modification had no effect on the binding of ␤-catenin to Tcf, but it prevented the carboxyl tail of ␤-catenin from sterically hindering binding between the arm repeat region of ␤-catenin and a TATA-binding protein. Despite the lack of effect on the interaction with Tcf, increased binding to TATA-binding protein increased ␤-catenin/Tcf transcriptional activity. ␤-Catenin is also a target for the neuronal cyclin-dependent kinase p35/ Cdk5 (44) , which also phosphorylates ␤-catenin in both the Nand C-terminal regions (45) . In cortical neurones p35/Cdk5 is found associated with a ␤-catenin/N-cadherin complex, and phosphorylation of ␤-catenin by p35/Cdk5 decreased ␤-catenin/ N-cadherin binding (44) . Inhibition of p35-Cdk5 phosphorylation of ␤-catenin was also shown to reduce PS1 binding to ␤-catenin (45) . Thus, kinase activity may be the molecular mechanism that modifies ␤-catenin, changing it from the refractory form to the signaling competent form, and PS1 appears to be closely involved in regulating the activity of that subfraction of ␤-catenin as well as exerting an antagonistic effect on stabilization higher up in the Wnt pathway. That p35/Cdk5 may be involved in PS1 inhibition of ␤-catenin transcription is of great interest as this kinase complex has already been implicated in other aspects of Alzheimer's disease pathology (46, 47) .
